Plasma Protein Kallikrein-14 Strongly Predicts Pronounced Chromogranin A (CgA) Response in Small Intestinal Neuroendocrine Tumor (NET) Patients after Somatostatin Analog (SSA) Treatment : The Nordic EXPLAIN Biomarker Study

Magnus Kjellman,U. Knigge,Staffan Welin,Henning Grønbæk,Espen Thiis-Evensen,Halfdan Sorbye,M. T. Joergensen,Viktor Johanson,Metso Si,Becker Kj,Torbjörn Ström,R. Belusa

Plasma Protein Kallikrein-14 Strongly Predicts Pronounced Chromogranin A (CgA) Response in Small Intestinal Neuroendocrine Tumor (NET) Patients after Somatostatin Analog (SSA) Treatment : The Nordic EXPLAIN Biomarker Study

2018

Magnus Kjellman
U. Knigge
Staffan Welin
Henning Grønbæk
Espen Thiis-Evensen
Halfdan Sorbye
M. T. Joergensen
Viktor Johanson
Metso Si
Becker Kj
Torbjörn Ström
R. Belusa

Plasma Protein Kallikrein-14 Strongly Predicts Pronounced Chromogranin A (CgA) Response in Small Intestinal Neuroendocrine Tumor (NET) Patients after Somatostatin Analog (SSA) Treatment : The Nordic EXPLAIN Biomarker Study

Keywords:

Small Intestinal Neuroendocrine Tumor
Biomarker (medicine)
Endocrinology
Chemistry
Chromogranin A
Blood proteins
Somatostatin analog
Kallikrein
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations